Muhammad Irfanur Rashid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Irfanur Rashid has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Yohei Okada
Department of Neurology, Aichi Medical University School of Medicine, Nagakute, Japan
2 shared publications - Akinobu Ota
Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan
1 shared publication Aline M.S. Yamashita
Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
1 shared publication- Arreh Jain
Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
1 shared publication Ayumu Matsushima
Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya 464-8603, Japan
1 shared publicationDaisuke Shimojo
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (11) , 103119
Donor-intrinsic regenerative potential outweighs histocompatibility in iPSC-derived skeletal muscle engraftment in nonhuman primates
- 15 October 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (11) , 103119
Open AccessDonor-intrinsic regenerative potential outweighs histocompatibility in iPSC-derived skeletal muscle engraftment in nonhuman primates
- Open Access
Early pathogenesis of spinal and bulbar muscular atrophy uncovered by human iPSC-derived motor neurons highlights pathogenic neuropeptides as therapeutic targets
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by the expansion of the polyglutamine tract in the androgen receptor (AR). Motor neurons (MNs) derived from patient-specific induced pluripotent stem cells (iPSCs) robustly recapitulated early SBMA phenotypes driven by endogenous mutant AR in the absence of testosterone (dihydrotestosterone) and detectable mutant AR aggregation. Notably, endoplasmic reticulum stress markedly exacerbated SBMA pathology. Cross-species integrative analyses of patient-derived neurons and spinal cords of transgenic mouse models revealed high expression of multiple disease-associated neuropeptides, including urotensin II (UTS2), in patient spinal MNs that was correlated with disease onset and progression in iPSC-derived MNs. Downstream signaling analyses of these neuropeptides revealed convergent molecular pathways whose pharmacological inhibition rescued cellular phenotypes. Together, these results establish a human disease model harboring endogenous mutant AR that closely reproduces early SBMA pathology and provides molecular leads for elucidating disease mechanisms and biomarkers and developing therapeutic targets.
Open AccessEarly pathogenesis of spinal and bulbar muscular atrophy uncovered by human iPSC-derived motor neurons highlights pathogenic neuropeptides as therapeutic targets
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by the expansion of the polyglutamine tract in the androgen receptor (AR). Motor neurons (MNs) derived from patient-specific induced pluripotent stem cells (iPSCs) robustly recapitulated early SBMA phenotypes driven by endogenous mutant AR in the absence of testosterone (dihydrotestosterone) and detectable mutant AR aggregation. Notably, endoplasmic reticulum stress markedly exacerbated SBMA pathology. Cross-species integrative analyses of patient-derived neurons and spinal cords of transgenic mouse models revealed high expression of multiple disease-associated neuropeptides, including urotensin II (UTS2), in patient spinal MNs that was correlated with disease onset and progression in iPSC-derived MNs. Downstream signaling analyses of these neuropeptides revealed convergent molecular pathways whose pharmacological inhibition rescued cellular phenotypes. Together, these results establish a human disease model harboring endogenous mutant AR that closely reproduces early SBMA pathology and provides molecular leads for elucidating disease mechanisms and biomarkers and developing therapeutic targets.
- 28 May 2025
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 140 (2) , 98-106
Construction of contractile human iPSC-derived skeletal muscle tissues on 96-well scale microdevices
- 28 May 2025
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 140 (2) , 98-106
Construction of contractile human iPSC-derived skeletal muscle tissues on 96-well scale microdevices